H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report
H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
H. Lundbeck (Lundbeck or 'the company') is a specialty pharmaceutical company primarily focusing on brain diseases. The company primarily operates in the US and Europe. It is headquartered in Valby, Denmark and employed 5,665 people as on December 31, 2014.
Detailed information on H. Lundbeck A/S required for business and competitor intelligence needs
A study of the major internal and external factors affecting H. Lundbeck A/S in the form of a SWOT analysis
An in-depth view of the business model of H. Lundbeck A/S including a breakdown and examination of key business segments
Intelligence on H. Lundbeck A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about H. Lundbeck A/S, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of H. Lundbeck A/S and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess H. Lundbeck A/S as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on H. Lundbeck A/S's business structure, strategy and prospects.